Caffeine citrate
Cafcit, Nymusa, Peyona (caffeine, citrated) is a small molecule pharmaceutical. Caffeine, citrated was first approved as Cafcit on 1999-09-21. It has been approved in Europe to treat apnea. The pharmaceutical is active against adenosine receptor A2a, adenosine receptor A3, adenosine receptor A2b, and adenosine receptor A1.
| Trade Name | Nymusa, Peyona |
|---|---|
| Common Name | Caffeine citrate |
| Indication | apnea |
| Drug Class |
